SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Feychting Maria) "

Sökning: WFRF:(Feychting Maria)

  • Resultat 1-25 av 79
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Sampson, Joshua N., et al. (författare)
  • Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types
  • 2015
  • Ingår i: Journal of the National Cancer Institute. - : Oxford University Press (OUP). - 0027-8874 .- 1460-2105. ; 107:12
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Studies of related individuals have consistently demonstrated notable familial aggregation of cancer. We aim to estimate the heritability and genetic correlation attributable to the additive effects of common single-nucleotide polymorphisms (SNPs) for cancer at 13 anatomical sites. Methods: Between 2007 and 2014, the US National Cancer Institute has generated data from genome-wide association studies (GWAS) for 49 492 cancer case patients and 34 131 control patients. We apply novel mixed model methodology (GCTA) to this GWAS data to estimate the heritability of individual cancers, as well as the proportion of heritability attributable to cigarette smoking in smoking-related cancers, and the genetic correlation between pairs of cancers. Results: GWAS heritability was statistically significant at nearly all sites, with the estimates of array-based heritability, h(l)(2), on the liability threshold (LT) scale ranging from 0.05 to 0.38. Estimating the combined heritability of multiple smoking characteristics, we calculate that at least 24% (95% confidence interval [CI] = 14% to 37%) and 7% (95% CI = 4% to 11%) of the heritability for lung and bladder cancer, respectively, can be attributed to genetic determinants of smoking. Most pairs of cancers studied did not show evidence of strong genetic correlation. We found only four pairs of cancers with marginally statistically significant correlations, specifically kidney and testes (rho = 0.73, SE = 0.28), diffuse large B-cell lymphoma (DLBCL) and pediatric osteosarcoma (rho = 0.53, SE = 0.21), DLBCL and chronic lymphocytic leukemia (CLL) (rho = 0.51, SE = 0.18), and bladder and lung (rho = 0.35, SE = 0.14). Correlation analysis also indicates that the genetic architecture of lung cancer differs between a smoking population of European ancestry and a nonsmoking Asian population, allowing for the possibility that the genetic etiology for the same disease can vary by population and environmental exposures. Conclusion: Our results provide important insights into the genetic architecture of cancers and suggest new avenues for investigation.
  •  
2.
  • Wang, Zhaoming, et al. (författare)
  • Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33
  • 2014
  • Ingår i: Human Molecular Genetics. - : Oxford University Press (OUP). - 0964-6906 .- 1460-2083. ; 23:24, s. 6616-6633
  • Tidskriftsartikel (refereegranskat)abstract
    • Genome-wide association studies (GWAS) have mapped risk alleles for at least 10 distinct cancers to a small region of 63 000 bp on chromosome 5p15.33. This region harbors the TERT and CLPTM1L genes; the former encodes the catalytic subunit of telomerase reverse transcriptase and the latter may play a role in apoptosis. To investigate further the genetic architecture of common susceptibility alleles in this region, we conducted an agnostic subset-based meta-analysis (association analysis based on subsets) across six distinct cancers in 34 248 cases and 45 036 controls. Based on sequential conditional analysis, we identified as many as six independent risk loci marked by common single-nucleotide polymorphisms: five in the TERT gene (Region 1: rs7726159, P = 2.10 × 10(-39); Region 3: rs2853677, P = 3.30 × 10(-36) and PConditional = 2.36 × 10(-8); Region 4: rs2736098, P = 3.87 × 10(-12) and PConditional = 5.19 × 10(-6), Region 5: rs13172201, P = 0.041 and PConditional = 2.04 × 10(-6); and Region 6: rs10069690, P = 7.49 × 10(-15) and PConditional = 5.35 × 10(-7)) and one in the neighboring CLPTM1L gene (Region 2: rs451360; P = 1.90 × 10(-18) and PConditional = 7.06 × 10(-16)). Between three and five cancers mapped to each independent locus with both risk-enhancing and protective effects. Allele-specific effects on DNA methylation were seen for a subset of risk loci, indicating that methylation and subsequent effects on gene expression may contribute to the biology of risk variants on 5p15.33. Our results provide strong support for extensive pleiotropy across this region of 5p15.33, to an extent not previously observed in other cancer susceptibility loci.
  •  
3.
  • Jacobs, Kevin B, et al. (författare)
  • Detectable clonal mosaicism and its relationship to aging and cancer.
  • 2012
  • Ingår i: Nature Genetics. - New York : Nature Publishing Group. - 1061-4036 .- 1546-1718. ; 44:6, s. 651-658
  • Tidskriftsartikel (refereegranskat)abstract
    • In an analysis of 31,717 cancer cases and 26,136 cancer-free controls from 13 genome-wide association studies, we observed large chromosomal abnormalities in a subset of clones in DNA obtained from blood or buccal samples. We observed mosaic abnormalities, either aneuploidy or copy-neutral loss of heterozygosity, of >2 Mb in size in autosomes of 517 individuals (0.89%), with abnormal cell proportions of between 7% and 95%. In cancer-free individuals, frequency increased with age, from 0.23% under 50 years to 1.91% between 75 and 79 years (P = 4.8 × 10(-8)). Mosaic abnormalities were more frequent in individuals with solid tumors (0.97% versus 0.74% in cancer-free individuals; odds ratio (OR) = 1.25; P = 0.016), with stronger association with cases who had DNA collected before diagnosis or treatment (OR = 1.45; P = 0.0005). Detectable mosaicism was also more common in individuals for whom DNA was collected at least 1 year before diagnosis with leukemia compared to cancer-free individuals (OR = 35.4; P = 3.8 × 10(-11)). These findings underscore the time-dependent nature of somatic events in the etiology of cancer and potentially other late-onset diseases.
  •  
4.
  • Adel Fahmideh, Maral, et al. (författare)
  • A Weighted Genetic Risk Score of Adult Glioma Susceptibility Loci Associated with Pediatric Brain Tumor Risk.
  • 2019
  • Ingår i: Scientific reports. - : Springer Science and Business Media LLC. - 2045-2322. ; 9:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Genetic risk score (GRS) is used to demonstrate the genetic variants contributing to the polygenic architecture of complex diseases. By using a GRS, we have investigated the additive impact of the known adult glioma susceptibility loci on the pediatric brain tumor (PBT) risk and assessed the proportion of PBT heritability attributable to these susceptibility loci. A GRS was generated for PBTs based on the alleles and associated effect sizes derived from a previously published genome-wide association study on adult glioma. The GRS was calculated in CEFALO, a population-based case-control study of brain tumors in children and adolescents including saliva DNA of 245 cases and 489 controls. The unconditional logistic regression model was used to investigate the association between standardized GRS and risk of PBTs. To measure the variance explained by the effect of GRS, Nagelkerke pseudo-R2 was calculated. The GRS for adult brain tumors was associated with an increased risk of PBTs (OR 1.25 [95% CI 1.06-1.49], p=0.009) and 0.3% of the variance in PBTs could be explained by the effect of GRS on the liability scale. This study provides evidence that heritable risks of PBTs are in-part attributable to some common genetic variants associated with adult glioma.
  •  
5.
  • Adel Fahmideh, Maral, et al. (författare)
  • Common genetic variations in cell cycle and DNA repair pathways associated with pediatric brain tumor susceptibility
  • 2016
  • Ingår i: Oncotarget. - Stockholm : Karolinska Institutet, Institute of Environmental Medicine. - 1949-2553.
  • Tidskriftsartikel (refereegranskat)abstract
    • Knowledge on the role of genetic polymorphisms in the etiology of pediatric brain tumors (PBTs) is limited. Therefore, we investigated the association between single nucleotide polymorphisms (SNPs), identified by candidate gene-association studies on adult brain tumors, and PBT risk. The study is based on the largest series of PBT cases to date. Saliva DNA from 245 cases and 489 controls, aged 7–19 years at diagnosis/reference date, was genotyped for 68 SNPs. Data were analyzed using unconditional logistic regression. The results showed EGFRrs730437 and EGFRrs11506105 may decrease susceptibility to PBTs, whereas ERCC1rs3212986 may increase risk of these tumors. Moreover, stratifid analyses indicated CHAF1Ars243341, CHAF1Ars2992, and XRCC1rs25487 were associated with a decreased risk of astrocytoma subtype. Furthermore, an increased risk of non-astrocytoma subtype associated with EGFRrs9642393, EME1rs12450550, ATMrs170548, and GLTSCRrs1035938 as well as a decreased risk of this subtype associated with XRCC4rs7721416 and XRCC4rs2662242 were detected. This study indicates SNPs in EGFR, ERCC1, CHAF1A, XRCC1, EME1, ATM, GLTSCR1, and XRCC4 may be associated with the risk of PBTs. Therefore, cell cycle and DNA repair pathways variations associated with susceptibility to adult brain tumors also seem to be associated with PBT risk, suggesting pediatric and adult brain tumors might share similar etiological pathways.
  •  
6.
  • Adel Fahmideh, Maral, et al. (författare)
  • Parental age and risk of genetic syndromes predisposing to nervous system tumors: nested case-control study.
  • 2018
  • Ingår i: Clinical epidemiology. - 1179-1349. ; 10, s. 729-738
  • Tidskriftsartikel (refereegranskat)abstract
    • Phacomatoses are genetic syndromes that are associated with increased risk of developing nervous system tumors. Phacomatoses are usually inherited, but many develop de novo, with unknown etiology. In this population-based study, we investigated the effect of parental age on the risk of phacomatoses in offspring.The study was a population-based nested case-control study. All individuals born and residing in Sweden between January 1960 and December 2010 were eligible for inclusion. Using the Patient Register, 4625 phacomatosis cases were identified and further classified as familial or nonfamilial. Ten matched controls per case were randomly selected from the eligible population. Data were analyzed using conditional logistic regression. Analyses were conducted for neurofibromatosis alone (n=2089) and other phacomatoses combined (n=2536).Compared with offspring of fathers aged 25-29 years, increased risk estimates of nonfamilial neurofibromatosis were found for offspring of fathers aged 35-39 years (odds ratio [OR]=1.43 [95% CI 1.16-1.74]) and ≥40 years (OR =1.74 [95% CI 1.38-2.19]). For other nonfamilial phacomatoses, the risk estimate for offspring of fathers aged ≥40 years was OR =1.23 (95% CI 1.01-1.50). Paternal age was not associated with familial phacomatoses, and no consistent association was observed with maternal age.The findings show a consistent increase in risk of de novo occurrence of phacomatoses predisposing to nervous system tumors in offspring with increasing paternal age, most pronounced for neurofibromatosis, while maternal age did not seem to influence the risk. These findings suggest an increasing rate of new mutations in the NF1 and NF2 genes in spermatozoa of older fathers.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  •  
11.
  •  
12.
  •  
13.
  •  
14.
  •  
15.
  • Ahlbom, Anders, et al. (författare)
  • Forskning om elöverkänslighet och andra effekter av elektromagnetiska fält; Åttonde årsrapporten
  • 2011
  • Rapport (övrigt vetenskapligt/konstnärligt)abstract
    • Årets rapport diskuterar några forskningsområden där resultaten är av stor betydelse och som kan förväntas tilldra sig stor uppmärksamhet. Det första avser möjligheterna att skatta exponering och den relativa betydelsen av olika exponeringskällor. Viktigt arbete har där gjorts inom det Schweiziska nationella forskningsprogrammet. Vi har inkluderat en figur som på ett enkelt sätt sammanfattar viktiga och relevanta resultat avseende exponering i den allmänna miljön. Det framgår att basstationer, egen mobiltelefonanvändning och trådlösa hemtelefoner är de viktigaste källorna till exponering (om man bortser från lokal exponering till huvudet under samtal). Nästa område avser sömn och EEG-undersökningar. Det har där visat sig i ett antal undersökningar att elektromagnetiska fält tycks ha effekt på EEG under sömn. Effekterna är måttliga och kan storleksmässigt jämföras med vad som kan erhållas till exempel vid kaffe- eller alkoholintag. De tycks inte vara kopplade till subjektiv sömnkvalitet. Hur dessa effekter uppstår och vad de kan tänkas ha för betydelse är okänt. Men det är klart att det är angeläget att forskningen inom detta område fortsätter så att vi kan få denna effekt bekräftad om den är reell och ytterligare belyst och förstådd. Vi har också beskrivit en del ytterligare epidemiologisk forskning och framför allt slutrapporten från den så kallade Interphone-studien. Det har funnits förhoppningar om att denna studie skulle kunna ge definitivt besked i frågan om mobiltelefonanvändning och hjärntumörrisk. Men det stod redan efter publiceringen av de nationella rapporterna klart att så knappast skulle bli fallet. Rapporten har gett upphov till omfattande metodologiska diskussioner, vilka också varit orsaken till rapportens stora försening. Vår bedömning är att denna rapport inte ändrar våra tidigare bedömningar av risken för hjärntumör vid mobiltelefonanvändning, baserade bland annat på vad som framkommit i de nationella rapporterna. Däremot har denna rapport och andra rapporter från Interphone bidragit med viktiga metodologiska insikter. Vi diskuterar några ytterligare epidemiologiska undersökningar men inte heller de ändrar någonting i våra bedömningar. Slutligen presenterar vi nya riktlinjer för exponering från ”kraftfrekventa elektromagnetiska fält” från ICNIRP. De är baserade på en uppdaterad kunskapsgenomgång och på omfattande principdiskussioner. Bland annat har man nu bedömt att också fotofosfener (ljusblixtar) ska ingå bland kritiska effekter vilket i viss mån har påverkat gränsvärdena numeriskt. Detta har dock ingen praktisk betydelse för allmänhetens exponering därför att nivåerna ändå ligger flera storleksordningar över vad allmänheten normalt exponeras för. Det finns dock arbetsmiljöer där detta kan ha betydelse. En viktiga händelse under 2011 som redan nu kan förutses är att IARC (WHOs cancerforskningsinstitut) i maj ska ha ett så kallat monografimöte och ta ställning till hur sannolikt det är att radiofrekventa elektromagnetiska fält är cancerframkallande.
  •  
16.
  • Ahlbom, Anders, et al. (författare)
  • Occupational magnetic field exposure and myocardial infarction incidence.
  • 2004
  • Ingår i: Epidemiology. - : Ovid Technologies (Wolters Kluwer Health). - 1044-3983 .- 1531-5487. ; 15:4, s. 403-8
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Studies on healthy volunteers have seen reduced heart rate variability after exposure to extremely low-frequency electric and magnetic fields (EMF). Because reduced heart rate variability has been linked to cardiovascular disease risk, it has been hypothesized that exposure to EMF might increase the risk of cardiovascular disease. One epidemiologic study has shown increased mortality from cardiovascular conditions in utility workers with elevated exposure to magnetic fields, but several other epidemiologic studies have failed to confirm this result. We tested the hypothesis that occupational EMF exposure increases the risk of myocardial infarction in a large population-based case-control study of myocardial infarction, with detailed information on potential confounders. METHODS: We used data from the SHEEP study, which is a population-based case-control study of acute myocardial infarction in Stockholm. Occupational EMF exposure was based on job titles 1, 5, and 10 years before diagnosis. We used 2 approaches to classify exposure: first, specific individual job titles with presumed elevated EMF exposure, and second, classification of subjects according to a job-exposure matrix. RESULTS: We found no increased risk of myocardial infarction in subjects classified as having elevated EMF exposure. For the highest exposure category of > or = 0.3 microT according to the job-exposure matrix, the adjusted relative risk was = 0.57 (95% confidence interval = 0.36-0.89). CONCLUSIONS: The results of this study do not support the hypothesis that occupational EMF exposure increases the risk of myocardial infarction.
  •  
17.
  • Ahlbom, Anders, et al. (författare)
  • Radiofrequency electromagnetic fields and risk of disease and ill health - Research during the last ten years
  • 2012
  • Rapport (övrigt vetenskapligt/konstnärligt)abstract
    • The focus of this report is electromagnetic fields of the type that occur in connection with mobile telephony, so called radio frequency (RF) fields and the possibility that exposure to such fields poses a risk of disease or ill health. The purpose is to describe what was known ten years ago, what we have learned during the past decade, and where we stand today. TEN YEARS AGOThe mechanism of interaction between RF fields and the human body was established long ago and is increased temperature of exposed tissue (compare microwave ovens). Methods for measurements of the fields in the air were developed early but the data on distribution of the absorbed energy in the human body was still restricted. Data regarding sources and levels of exposure to the population was limited because systematic measurements had not been conducted. A considerable number of provocation studies on exposure to fields of lower frequencies (related to electric power and computer screens) had already been conducted and had not found any evidence of an association to symptoms (headache, vertigo, dizziness, concentration difficulties, insomnia) but the corresponding information about RF fields and occurrence of symptoms was scarce. Few and methodologically limited epidemiological studies had been conducted on RF field exposure and cancer.WHAT WAS LEARNED DURING THE PAST TEN YEARSExtensive research on various aspects of RF fields has been conducted during the last ten years and the knowledge database has increased considerably. Simulation models have improved our knowledge about how the fields and the energy are distributed in the body. Mobile, so called, exposimeters have been developed for use in epidemiological studies. Many more measurements have been conducted to increase our knowledge about sources and level of exposure to the population. More than 15 provocation studies (single or double blind) have been conducted on symptoms attributed to exposure to RF fields. These studies have not been able to demonstrate that people experience symptoms or sensations more often when the fields are turned on than when they are turned off. One longitudinal study has looked at frequency of symptoms in relation to environmental exposure and this study found no association between exposure and symptoms. A considerable number of studies on cancer, and in particular brain tumor, were presented. As a consequence there exist now very useful data including methodological results that can be used in the interpretation of this research. With a small number of exceptions the available results are all negative and taken together with new methodological understandings the overall interpretation is that these do not provide support for an association between mobile telephony and brain tumor risk. In addition, national cancer statistics are very useful sources of information because mobile phone usage has increased so quickly. Had mobile phone use and brain cancer risk been associated it would have been visible as an increasing trend in national cancer statistics. But brain cancer rates are not increasing. WHERE WE STAND TODAYWe now know much more about measurements and absorption of RF fields and also about sources of exposure to the population and levels of exposure. A considerable number of provocation studies on RF exposure and symptoms have been unable to show any association. Overall, the data on brain tumor and mobile telephony do not support an effect of mobile phone use on tumor risk, in particular when taken together with national cancer trend statistics throughout the world. Research on mobile telephony and health started without a biologically or epidemiologically based hypothesis about possible health risks. Instead the inducement was an unspecific concern related to a new and rapidly spreading technology. Extensive research for more than a decade has not detected anything new regarding interaction mechanisms between radiofrequency fields and the human body and has found no evidence for health risks below current exposure guidelines. While absolute certainty can never be achieved, nothing has appeared to suggest that the since long established interaction mechanism of heating would not suffice as basis for health protection.
  •  
18.
  •  
19.
  • Andel, Ross, et al. (författare)
  • Work-related exposure to extremely low-frequency magnetic fields and dementia: results from the population-based study of dementia in Swedish twins.
  • 2010
  • Ingår i: The journals of gerontology. Series A, Biological sciences and medical sciences. - : Oxford University Press (OUP). - 1758-535X .- 1079-5006. ; 65:11, s. 1220-7
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: We examined the association between extremely low-frequency magnetic fields (EMF) and the risk of dementia and Alzheimer's disease using all 9,508 individuals from the Study of Dementia in Swedish Twins (HARMONY) with valid occupational and diagnostic data. METHODS: Dementia diagnoses were based on telephone screening followed by in-person clinical workup. Main lifetime occupation was coded according to an established EMF exposure matrix. Covariates were age, gender, education, vascular risk factors, and complexity of work. Based on previous research, data were also analyzed separately for cases with disease onset by age 75 years versus later, men versus women, and those with manual versus nonmanual main occupation. We used generalized estimating equations with the entire sample (to adjust for the inclusion of complete twin pairs) and conditional logistic regression with complete twin pairs only. RESULTS: Level of EMF exposure was not significantly associated with dementia or Alzheimer's disease. However, in stratified analyses, medium and high levels of EMF exposure were associated with increased dementia risk compared with low level in cases with onset by age 75 years (odds ratio: 1.94, 95% confidence interval: 1.07-3.65 for medium, odds ratio: 2.01, 95% confidence interval: 1.10-3.65 for high) and in participants with manual occupations (odds ratio: 1.81, 95% confidence interval: 1.06-3.09 for medium, odds ratio: 1.75, 95% confidence interval: 1.00-3.05 for high). Results with 42 twin pairs discordant for dementia did not reach statistical significance. CONCLUSIONS: Occupational EMF exposure appears relevant primarily to dementia with an earlier onset and among former manual workers.
  •  
20.
  • Andersson, Ulrika, et al. (författare)
  • A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk
  • 2010
  • Ingår i: Acta Oncologica. - : Informa Healthcare. - 0284-186X .- 1651-226X. ; 12, s. 17-17
  • Tidskriftsartikel (refereegranskat)abstract
    • Glioma is the most common type of adult brain tumor and glioblastoma, its most aggressive form, has a dismal prognosis. Receptor tyrosine kinases such as the epidermal growth factor receptor (EGFR, ERBB2, ERBB3, ERBB4) family, and the vascular endothelial growth factor receptor (VEGFR), play a central role in tumor progression. We investigated the genetic variants of EGFR, ERBB2, VEGFR and their ligands, EGF and VEGF on glioma and glioblastoma risk. In addition, we evaluated the association of genetic variants of a newly discovered family of genes known to interact with EGFR: LRIG2 and LRIG3 with glioma and glioblastoma risk. Methods. We analyzed 191 tag single nucleotide polymorphisms (SNPs) capturing all common genetic variation of EGF, EGFR, ERBB2, LRIG2, LRIG3, VEGF and VEGFR2 genes. Material from four case-control studies with 725 glioma patients (329 of who were glioblastoma patients) and their 1 610 controls was used. Haplotype analyses were conducted using SAS/Genetics software. Results. Fourteen of the SNPs were significantly associated with glioma risk at p< 0.05, and 17 of the SNPs were significantly associated with glioblastoma risk at p< 0.05. In addition, we found that one EGFR haplotype was related to increased glioblastoma risk at p=0.009, Odds Ratio [OR] = 1.67 (95% confidence interval (CI): 1.14, 2.45). The Bonferroni correction made all p-values non-significant. One SNP, rs4947986 next to the intron/exon boundary of exon 7 in EGFR, was validated in an independent data set of 713 glioblastoma and 2 236 controls, [OR] = 1.42 (95% CI: 1.06,1.91). Discussion. Previous studies show that regulation of the EGFR pathway plays a role in glioma progression but the present study is the first to find that certain genotypes of the EGFR gene may be related to glioblastoma risk. Further studies are required to reinvestigate these findings and evaluate the functional significance.
  •  
21.
  • Andersson, Ulrika, et al. (författare)
  • MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome.
  • 2009
  • Ingår i: International journal of cancer. Journal international du cancer. - : Wiley. - 1097-0215 .- 0020-7136. ; 125:4, s. 968-972
  • Tidskriftsartikel (refereegranskat)abstract
    • The human telomerase reverse transcriptase (hTERT) gene is upregulated in a majority of malignant tumours. A variable tandem repeat, MNS16A, has been reported to be of functional significance for hTERT expression. Published data on the clinical relevance of MNS16A variants in brain tumours have been contradictory. The present population-based study in the Nordic countries and the United Kingdom evaluated brain-tumour risk and survival in relation to MNS16A minisatellite variants in 648 glioma cases, 473 meningioma cases and 1,359 age, sex and geographically matched controls. By PCR-based genotyping all study subjects with fragments of 240 or 271 bp were judged as having short (S) alleles and subjects with 299 or 331 bp fragments as having long (L) alleles. Relative risk of glioma or meningioma was estimated with logistic regression adjusting for age, sex and country. Overall survival was analysed using Kaplan-Meier estimates and equality of survival distributions using the log-rank test and Cox proportional hazard ratios. The MNS16A genotype was not associated with risk of occurrence of glioma, glioblastoma (GBM) or meningioma. For GBM there were median survivals of 15.3, 11.0 and 10.7 months for the LL, LS and SS genotypes, respectively; the hazard ratio for having the LS genotype compared with the LL was significantly increased HR 2.44 (1.56-3.82) and having the SS genotype versus the LL was nonsignificantly increased HR 1.46 (0.81-2.61). When comparing the LL versus having one of the potentially functional variants LS and SS, the HR was 2.10 (1.41-3.1). However, functionality was not supported as there was no trend towards increasing HR with number of S alleles. Collected data from our and previous studies regarding both risk and survival for the MNS16A genotypes are contradictory and warrant further investigations.
  •  
22.
  • Aydin, Denis, et al. (författare)
  • Mobile phone use and brain tumors in children and adolescents: a multicenter case-control study.
  • 2011
  • Ingår i: Journal of the National Cancer Institute. - : Oxford University Press (OUP). - 1460-2105 .- 0027-8874. ; 103:16, s. 1264-76
  • Tidskriftsartikel (refereegranskat)abstract
    • It has been hypothesized that children and adolescents might be more vulnerable to possible health effects from mobile phone exposure than adults. We investigated whether mobile phone use is associated with brain tumor risk among children and adolescents.
  •  
23.
  • Bethke, Lara, et al. (författare)
  • CASP8 D302H and meningioma risk : an analysis of five case-control series
  • 2009
  • Ingår i: Cancer Letters. - Clare : Elsevier. - 0304-3835 .- 1872-7980. ; 273:2, s. 312-315
  • Tidskriftsartikel (refereegranskat)abstract
    • Caspase 8 (CASP8) is a key regulator of apoptosis or programmed cell death, and hence a defence against cancer. The CASP8 polymorphism D302H has recently been shown to influence the risk of breast cancer. We tested the hypothesis that the CASP8 polymorphism D302H may influence risk of meningioma through analysis of five independent series of case patients and controls (n=631 and 637, respectively). Carrier status for 302H was not associated with a statistically significantly increased risk (OR=1.16; 95% CI: 0.87-1.53; P=0.31) making it unlikely that this variant contributes to the inherited risk of meningioma.
  •  
24.
  • Bethke, Lara, et al. (författare)
  • Comprehensive analysis of DNA repair gene variants and risk of meningioma
  • 2008
  • Ingår i: Journal of the National Cancer Institute. - : Oxford University Press. - 0027-8874 .- 1460-2105. ; 100:4, s. 270-276
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Meningiomas account for up to 37% of all primary brain tumors. Genetic susceptibility to meningioma is well established, with the risk among relatives of meningioma patients being approximately threefold higher than that in the general population. A relationship between risk of meningioma and exposure to ionizing radiation is also well known and led us to examine whether variants in DNA repair genes contribute to disease susceptibility.Methods: We analyzed 1127 tagging single-nucleotide polymorphisms (SNPs) that were selected to capture most of the common variation in 136 DNA repair genes in five case–control series (631 case patients and 637 control subjects) from four countries in Europe. We also analyzed 388 putative functional SNPs in these genes for their association with meningioma. All statistical tests were two-sided.Results: The SNP rs4968451, which maps to intron 4 of the gene that encodes breast cancer susceptibility gene 1–interacting protein 1, was consistently associated with an increased risk of developing meningioma. Across the five studies, the association was highly statistically significant (trend odds ratio = 1.57, 95% confidence interval = 1.28 to 1.93; Ptrend = 8.95 × 10−6; P = .009 after adjusting for multiple testing).Conclusions: We have identified a novel association between rs4968451 and meningioma risk. Because approximately 28% of the European population are carriers of at-risk genotypes for rs4968451, the variant is likely to make a substantial contribution to the development of meningioma.
  •  
25.
  • Bethke, Lara, et al. (författare)
  • Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma
  • 2008
  • Ingår i: Human Molecular Genetics. - : Oxford University Press. - 0964-6906 .- 1460-2083. ; 17:6, s. 800-805
  • Tidskriftsartikel (refereegranskat)abstract
    • Much of the variation in inherited risk of glioma is likely to be explained by combinations of common low risk variants. The established relationship between glioma risk and exposure to ionizing radiation led us to examine whether variants in the DNA repair genes contribute to disease susceptibility. We evaluated 1127 haplotype-tagging single-nucleotide polymorphisms (SNPs) supplemented with 388 putative functional SNPs to capture most of the common variation in 136 DNA repair genes, in five unique case–control series from four different countries (1013 cases, 1016 controls). We identified 16 SNPs associated with glioma risk at the 1% significance level. The highest association observed across the five independent case–control datasets involved rs243356, which maps to intron 3 of CHAF1A (trend odds ratio, 1.32; 95% confidence interval 1.14–1.54; P = 0.0002; false-positive report probability = 0.055, based on a prior probability of 0.01). Our results provide additional support for the hypothesis that low penetrance variants contribute to the risk of developing glioma and suggest that a genetic variant located in or around the CHAF1A gene contributes to disease risk.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-25 av 79
Typ av publikation
tidskriftsartikel (67)
rapport (10)
bok (1)
konferensbidrag (1)
Typ av innehåll
refereegranskat (65)
övrigt vetenskapligt/konstnärligt (14)
Författare/redaktör
Feychting, Maria (79)
Ahlbom, Anders (36)
Johansen, Christoffe ... (28)
Henriksson, Roger (17)
Schüz, Joachim (15)
Talbäck, Mats (12)
visa fler...
Andersson, Ulrika (12)
Hamnerius, Yngve, 19 ... (12)
Hillert, Lena (12)
Auvinen, Anssi (12)
Swerdlow, Anthony (11)
Lönn, Stefan (11)
Malmer, Beatrice (10)
Tettamanti, Giorgio (9)
Röösli, Martin (9)
Melin, Beatrice S. (9)
Kiuru, Anne (9)
Muir, Kenneth (8)
Chanock, Stephen J (8)
Yeager, Meredith (8)
Hartge, Patricia (8)
Schoemaker, Minouk (8)
Rajaraman, Preetha (8)
Wang, Zhaoming (8)
Mathiesen, Tiit (7)
Ljung, Rickard (7)
White, Emily (7)
Peters, Ulrike (7)
Kitahara, Cari M. (7)
Chatterjee, Nilanjan (7)
Gaziano, J Michael (7)
McKean-Cowdin, Rober ... (7)
Wang, Sophia S. (7)
Salminen, Tiina (7)
Gapstur, Susan M (6)
Stevens, Victoria L (6)
Albanes, Demetrius (6)
Giles, Graham G (6)
Tynes, Tore (6)
Prochazka, Michaela (6)
Visvanathan, Kala (6)
Severi, Gianluca (6)
Hallmans, Göran (6)
Shu, Xiao-Ou (6)
Zheng, Wei (6)
Houlston, Richard (6)
Zeleniuch-Jacquotte, ... (6)
Rothman, Nathaniel (6)
Purdue, Mark P. (6)
Linet, Martha S. (6)
visa färre...
Lärosäte
Karolinska Institutet (62)
Umeå universitet (31)
Uppsala universitet (26)
Lunds universitet (13)
Chalmers tekniska högskola (12)
Göteborgs universitet (8)
visa fler...
Stockholms universitet (5)
Örebro universitet (5)
Linköpings universitet (3)
visa färre...
Språk
Engelska (68)
Svenska (10)
Norska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (65)
Teknik (12)
Samhällsvetenskap (3)
Naturvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy